Events Search and Views Navigation
September 2019
CeBIL Annual Symposium 2019: Legal Innovation to Support the Development of Antimicrobial Drugs
This symposium explores the complex interactions between law and antimicrobial research and development. Advancing our understanding of this ecosystem will help design a better legal toolkit to promote antimicrobial innovation and limit the impact of resistance on global health. Held at the University of Cambridge, an international hub for legal and scientific expertise, we hope the event will mobilize legal, economic, business, medical and scientific experts – early, mid, and late career – who recognize the need to work together…
Find out more »CARB-X Product Developer Conference
We are excited to announce that CARB-X will be hosting our first ever CARB-X Developer Conference. The conference will be held on September 6th, 2019 in Boston, immediately following the conclusion of the ASM-ESCMID conference. Additional details will follow. Please save the date! This will be an excellent networking event for CARB-X product developers, who will have the opportunity to connect with and learn from some of the most innovative members of the AMR community, including companies in our diverse portfolio as well as representatives…
Find out more »Institut Pasteur Financing Start-Up Breakfast
Additional Details Forthcoming.
Find out more »October 2019
IDWeek 2019 Annual Conference
Attendees include Richard Alm, CARB-X Alliance Director. IDWeek is the joint annual meeting of the Infectious Diseases Society of America (IDSA), Society for Healthcare Epidemiology of America (SHEA), the HIV Medical Association (HIVMA), and the Pediatric Infectious Diseases Society (PIDS). At IDWeek, you will see familiar colleagues and new faces. IDWeek is a forum for health professionals of varied backgrounds to collaborate, cooperate, and learn from each other’s expertise. With so many common issues and challenges cutting across our four…
Find out more »Institut Pasteur – International Course on Antibiotics and Resistance (ICARE)
Speakers include Karen Gallant, CARB-X Global R&D Project Director. The emergence and spread of bacteria resistant to many drug classes seriously threaten all branches of modern medicine. There is currently no course providing advanced instruction on antibiotics and resistance. The specific goal of ICARe is to bring leaders in academics and industry together with trained scientists at the dawn of their careers. Cutting-edge approaches for detection of resistance and antibiotic discovery, chemical optimization, and usage that minimizes the development of…
Find out more »